Brendan M. Boyle

Pediatric Gastroenterology
700 Childrens Dr
Columbus, OH 43205

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 92 publications

Esophageal Eosinophilia in Pediatric and Young Adult Patients with Inflammatory Bowel Disease: Diagnosis, Clinical Course, and Treatment Outcomes.

Esophageal Eosinophilia in Pediatric and Young Adult Patients with Inflammatory Bowel Disease: Diagnosis, Clinical Course, and Treatment Outcomes.

Journal: Children (Basel, Switzerland)
Published: May 13, 2026

Induction-phase infliximab monitoring accelerates time to remission in pediatric IBD: a retrospective cohort study.

Induction-phase infliximab monitoring accelerates time to remission in pediatric IBD: a retrospective cohort study.

Journal: Crohn's & colitis 360
Published: April 21, 2026

Pharmacometric Targets During Anti-TNF Induction and Their Association with Deep Remission in Pediatric Crohn's Disease.

Pharmacometric Targets During Anti-TNF Induction and Their Association with Deep Remission in Pediatric Crohn's Disease.

Journal: Clinical pharmacokinetics
Published: January 14, 2026

Outcomes of adalimumab biosimilar nonmedical switches in children and young adults with inflammatory bowel disease.

Outcomes of adalimumab biosimilar nonmedical switches in children and young adults with inflammatory bowel disease.

Journal: JPGN reports
Published: November 19, 2025

Automated Eosinophil Quantification Using Deep Learning to Predict Therapy Escalation in Pediatric Ulcerative Colitis.

Automated Eosinophil Quantification Using Deep Learning to Predict Therapy Escalation in Pediatric Ulcerative Colitis.

Journal: Clinical and translational gastroenterology
Published: November 19, 2025

The biosimilar shift: trending infliximab biosimilar utilization and associated cost savings for commercial insurance.

The biosimilar shift: trending infliximab biosimilar utilization and associated cost savings for commercial insurance.

Journal: The American journal of managed care
Published: October 27, 2025

Frequency and impact of repeat colonoscopy as a treat-to-target approach in pediatric inflammatory bowel disease.

Frequency and impact of repeat colonoscopy as a treat-to-target approach in pediatric inflammatory bowel disease.

Journal: JPGN reports
Published: October 08, 2025

Model-informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's Disease.

Model-informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's Disease.

Journal: bioRxiv : the preprint server for biology
Published: August 12, 2025

Evaluation of pharmacokinetic metrics and pharmacodynamic biomarkers associated with endoscopic healing in pediatric Crohn's disease patients treated with anti-tumor necrosis factor biologics.

Evaluation of pharmacokinetic metrics and pharmacodynamic biomarkers associated with endoscopic healing in pediatric Crohn's disease patients treated with anti-tumor necrosis factor biologics.

Journal: Crohn's & colitis 360
Published: August 05, 2025

Hybrid Population PK-Machine Learning Modeling to Predict Infliximab Pharmacokinetics in Pediatric and Young Adult Patients with Crohn's Disease.

Hybrid Population PK-Machine Learning Modeling to Predict Infliximab Pharmacokinetics in Pediatric and Young Adult Patients with Crohn's Disease.

Journal: bioRxiv : the preprint server for biology
Published: July 14, 2025

Model-Informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's Disease.

Model-Informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's Disease.

Journal: Clinical pharmacology and therapeutics
Published: July 14, 2025

Assessing attitudes, access, barriers, and facilitators to multidisciplinary care in pediatric inflammatory bowel disease.

Assessing attitudes, access, barriers, and facilitators to multidisciplinary care in pediatric inflammatory bowel disease.

Journal: JPGN reports
Published: July 01, 2025
Showing 1-12 of 92

Last Updated: 09/26/2026